Alternative Treatment (DBCOND0088155)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Fingolimod	A sphingosine 1-phosphate receptor modulator used to treat patients with the relapsing-remitting form of multiple sclerosis (MS) and studied to manage lung complications of COVID-19.	Sphingosine 1-phosphate receptor 5target Sphingosine kinase 1enzyme Cytochrome P450 2E1enzyme Cytochrome P450 4F2enzyme Histone deacetylase 1target Excitatory amino acid transporter 2transporter Excitatory amino acid transporter 1transporter ATP-dependent translocase ABCB1transporter Multidrug resistance-associated protein 1transporter Sphingosine 1-phosphate receptor 1target Sphingosine 1-phosphate receptor 4target Sphingosine 1-phosphate receptor 3target D(3) dopamine receptortarget Sphingosine kinase 1target

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT03911414	A Clinical Trial Via Telepsychiatry of Treatments for the Management of Emotional Dysregulation in Youth	Acetylcysteine Inositol Omega-3 fatty acids	treatment	4	recruiting
NCT03100045	Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)	Artemisinin Artesunate	treatment	1	completed